These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 8442452)

  • 1. Ingredient labeling of prescription drug products.
    Houlihan GM; Calhoon PH
    Am J Hosp Pharm; 1993 Mar; 50(3):443. PubMed ID: 8442452
    [No Abstract]   [Full Text] [Related]  

  • 2. Iatrogenic diarrhea caused by sorbitol.
    Shelly MS
    J Fam Pract; 1993 Jan; 36(1):95-6. PubMed ID: 8419508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FDA's regulation of prescription drug labeling: a role for implied preemption.
    Kendrick LC
    Food Drug Law J; 2007; 62(1):227-47. PubMed ID: 17444031
    [No Abstract]   [Full Text] [Related]  

  • 4. Presumption of innocence: FDA's authority to regulate the specifics of prescription drug labeling and the preemption debate.
    Dorfman HL; Quinn VM; Brophy EA
    Food Drug Law J; 2006; 61(4):585-622. PubMed ID: 17180765
    [No Abstract]   [Full Text] [Related]  

  • 5. Requirements on content and format of labeling for human prescription drug and biological products. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2006 Jan; 71(15):3921-97. PubMed ID: 16479698
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The case for preemption of prescription drug failure-to-warn claims.
    Kim CH
    Food Drug Law J; 2007; 62(2):399-422. PubMed ID: 17632969
    [No Abstract]   [Full Text] [Related]  

  • 7. Which prescription for the illegible and unreadable DTC (direct-to-consumer) brief summary--major surgery or euthanasia?
    Hochhauser M
    Manag Care Q; 2002; 10(3):6-10. PubMed ID: 12476659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prescription drug products; patient labeling requirements: proposed rule.
    Fed Regist; 1979 Jul; 44(131 Pt 2):40015-41. PubMed ID: 10242793
    [No Abstract]   [Full Text] [Related]  

  • 9. Prescriptions: how your doctor makes the choice.
    Shapiro JP; Schultz S
    US News World Rep; 2001 Feb; 130(7):58-61. PubMed ID: 11225095
    [No Abstract]   [Full Text] [Related]  

  • 10. APhA-ASIM statement on . . . prescription writing and prescription labeling.
    Ohio State Med J; 1975 Mar; 71(3):194. PubMed ID: 1124190
    [No Abstract]   [Full Text] [Related]  

  • 11. Requirements for submission of labeling for human prescription drugs and biologics in electronic format. Final rule.
    Food and Drug Administration, HHS
    Fed Regist; 2003 Dec; 68(238):69009-20. PubMed ID: 14672084
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prescription drug products; revocation of patient package insert requirements--Food and Drug Administration. Final rule.
    Fed Regist; 1982 Sep; 47(173):39147-55. PubMed ID: 10258154
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Food and Drug Administration--Prescription drug products; patient package inserts requirements. Final rule.
    Fed Regist; 1980 Sep; 45(179 Pt 2):60754-84. PubMed ID: 10248285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Off-label promotion, on-target sales.
    Fugh-Berman A; Melnick D
    PLoS Med; 2008 Oct; 5(10):e210. PubMed ID: 18959472
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exploring generic drug use behavior: the role of prescribers and pharmacists in the opportunity for generic drug use and generic substitution.
    Mott DA; Cline RR
    Med Care; 2002 Aug; 40(8):662-74. PubMed ID: 12187180
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Improving prescription drug labeling.
    Wolf MS; Bailey SC
    N C Med J; 2007; 68(5):340-2. PubMed ID: 18183755
    [No Abstract]   [Full Text] [Related]  

  • 17. Physicians, pharmacists, pharmaceutical manufacturers: partners in patient care, partners in litigation?
    Willig SH
    Spec Law Dig Health Care (Mon); 1987 Feb; 8(12):7-40. PubMed ID: 10280590
    [No Abstract]   [Full Text] [Related]  

  • 18. [Same drugs same names].
    Lønkvist HB
    Ugeskr Laeger; 2004 Apr; 166(17):1583. PubMed ID: 15146696
    [No Abstract]   [Full Text] [Related]  

  • 19. Increasing the odds of patient compliance through prescription warning labels.
    Ferguson JM; Discenza R; Miller JA
    J Health Care Mark; 1987 Mar; 7(1):37-46. PubMed ID: 10281382
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Off-label or off-limits?
    Ratner M; Gura T
    Nat Biotechnol; 2008 Aug; 26(8):867-75. PubMed ID: 18688236
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.